Kim Yong-il, Kang Hyun Guy, Kim Tae Sung, Kim Seok-ki, Kim June Hyuk, Kim Han Soo
Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Orthopaedic Oncology Clinic, National Cancer Center, Gyeonggido, Republic of Korea.
Surg Oncol. 2014 Dec;23(4):192-8. doi: 10.1016/j.suronc.2014.03.006. Epub 2014 Oct 2.
Percutaneous stabilization (PS; percutaneous flexible nailing and intramedullary bone cement injection) was performed at lower extremity long bones in patients with multiple bone metastases with short life expectancy to get mechanical stability and local tumor control. We evaluated the usefulness of PS by clinical status, F-18-FDG PET-CT and bone scintigraphy (BS).
Patients comprised 15 patients (total 20 sites) who had undergone PS for the metastatic bone tumors of lower extremity long bones (femur and tibia). After percutaneous flexible nailing, bone cement was injected (mean amount=15.5±6.4 ml). Patients' clinical status was evaluated by visual analog scale (VAS). Qualitative assessment of PET-CT and BS was categorized by improved, stable and aggravated states of PS lesion. Quantitative assessment of PET-CT was performed by maximum and mean standardized uptake value (SUVmax and SUVmean).
PS was performed in all of the patients without complication, and showed significant pain improvement of VAS (7.2±0.2 vs. 2.8±0.3, P<0.001). PS lesion showed improved state in 65% (13/20) and stable state in 35% (7/20). However, naive bony metastatic lesion showed mostly aggravated state in 90% (19/20) in the same patients, which was significantly different compared with PS lesion (P<0.001). In PS lesion, SUVmax (10.1±6.9 vs. 7.1±5.2, P=0.008) and SUVmean (6.2±4.8 vs. 4.6±3.7, P=0.008) showed significantly decreased uptake after PS.
By PS in lower extremity long bones, patients can reduce regional pain, and has the possibility of local tumor control. PS can be performed for lower extremity bone metastasis in poor general condition to perform conventional intramedullary nailing.
对预期寿命较短的多发骨转移患者的下肢长骨进行经皮稳定术(PS;经皮弹性髓内钉固定及髓内骨水泥注射),以获得机械稳定性并实现局部肿瘤控制。我们通过临床状况、F-18-FDG PET-CT及骨闪烁显像(BS)评估PS的有效性。
患者包括15例(共20处)因下肢长骨(股骨和胫骨)转移性骨肿瘤接受PS治疗的患者。经皮弹性髓内钉固定后,注射骨水泥(平均量=15.5±6.4 ml)。通过视觉模拟量表(VAS)评估患者的临床状况。PET-CT和BS的定性评估按PS病变的改善、稳定和加重状态分类。PET-CT的定量评估通过最大和平均标准化摄取值(SUVmax和SUVmean)进行。
所有患者均成功进行了PS,无并发症发生,VAS疼痛评分显著改善(7.2±0.2对2.8±0.3,P<0.001)。PS病变65%(13/20)呈改善状态,35%(7/20)呈稳定状态。然而,同一患者中未经处理的骨转移病变90%(19/20)大多呈加重状态,与PS病变相比差异有统计学意义(P<0.001)。在PS病变中,PS后SUVmax(10.1±6.9对7.1±5.2,P=0.008)和SUVmean(6.2±4.8对4.6±3.7,P=0.008)摄取显著降低。
通过对下肢长骨进行PS,患者可减轻局部疼痛,并有可能实现局部肿瘤控制。对于一般状况较差、无法进行传统髓内钉固定的下肢骨转移患者,可施行PS。